Pharos Capital-backed Verdi Oncology taps Herman as CEO

Verdi Oncology, which is backed by Pharos Capital, has beefed up its senior leadership team with several appointments.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this